Cowen & Co. Maintains Outperform on Amgen, Raises Price Target to $277

Cowen & Co. analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $253 to $277.

Benzinga · 12/20/2019 14:25

Cowen & Co. analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $253 to $277.